Results 181 to 190 of about 25,814 (203)
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941]. [PDF]
ESMO OpenArenare L, Di Liello R, De Placido P, Gridelli C, Morabito A, Pignata S, Nuzzo F, Avallone A, Maiello E, Gargiulo P, Schettino C, Gravina A, Gallo C, Chiodini P, Di Maio M, Perrone F, Piccirillo MC. +16 moreeuropepmc +1 more sourceGlobal consensus for the screening, diagnosis, staging, treatment, and surveillance of ovarian cancer in areas of significant resource limitations: report from the International Gynecological Cancer Society consensus meeting. [PDF]
Front OncolMaluf F, Helber HA, Tostes F, Maluf LA, Helito JK, Moretti-Marques R, Dal Molin GZ, Azevedo BRB, Ortiz DI, Cantu D, Silva Filho AL, Nogueira-Rodrigues A, Ribeiro R, Cintra GF, Guitmann G, de Melo AC, Paulino E, Baiocchi G, Resende L, de Almeida MS, de Andrade DA, de la Vega JL, Noll F, Fin F, Lopes A, Correa ME, Ng JS, Sanabria D, Rendon G, Heredia F, Lopes APE, Mussi MB, Bobinski M, Quintanilla MP, Meymar J, Atallah D, Tsunoda A. +36 moreeuropepmc +1 more sourceImmune classification of advanced melanoma identifies non-responders to anti-PD1 therapy. [PDF]
Cancer Immunol ImmunotherGámez-Pozo A, Trilla-Fuertes L, Becerril-Gómez F, Lalanda-Delgado P, Soriano V, Garicano Goldaraz F, Lecumberri MJ, Rodríguez de la Borbolla M, Majem M, Pérez-Ruiz E, González-Cao M, Oramas J, López-Vacas R, Magdaleno A, Fra J, Martín-Carnicero A, Corral M, Puértolas T, Ramos-Ruiz R, Espinosa E, Fresno Vara JÁ. +20 moreeuropepmc +1 more source
